Cannabis Market Intelligence

Q1 2026 Industry Report

Federal rescheduling and 280E relief mark the most significant cannabis regulatory shift since 1970

Q1 2026 marked a potential turning point for the U.S. cannabis industry, with a significant federal regulatory development reshaping the financial and strategic outlook for operators. Capital markets responded, and deal activity shifted. This report examines what the changes mean for valuations, M&A, and competitive positioning across the cannabis landscape.

#image_title

What's Inside the Q1 2026 Cannabis Industry Report

Market Trends & Operating Performance

  • How the DOJ’s Schedule III reclassification is changing the financial calculus for multi-state operators
  • Which state markets are emerging as the most consequential near-term legalization opportunities

Financial Performance & Valuation Insights

  • Where public market multiples are landing post-rescheduling and what’s driving the divergence
  • Which operators are outperforming on revenue and margin — and why the gap is widening

M&A Activity & Consolidation

  • What’s behind the modest uptick in deal activity and who is driving it
  • How the structure of recent transactions reflects shifting buyer priorities in a capital-constrained market

Regulatory & Policy Developments

  • What Schedule III reclassification means in practice for tax, banking, and research access
  • What to watch at the upcoming federal hearing on adult-use reclassification

Get Your Cannabis Industry Report

Complete the form below to instantly access the comprehensive Q1 2026 Cannabis Market Intelligence Report:


By downloading this report, you agree to receive future cannabis industry intelligence reports and related market insights from Houlihan Capital. Unsubscribe any time.

Industry update banner: Houlihan Capital logo over a cannabis plant with green geometric accents, Cannabis Market Q1 2026.
Team of professionals collaborating with laptops and notebooks, overlaid by a city skyline reflection.”

About Houlihan Capital's Cannabis Expertise

For over 25 years, Houlihan Capital has provided specialized financial services to cannabis businesses across cultivation, retail, processing, and ancillary services. Our team understands the unique valuation challenges, regulatory complexities, and strategic considerations that define success in this rapidly evolving industry.

Cannabis Services: Business Valuations | Fairness Opinions | Transaction Advisory | Exit Planning | Compliance-Ready Financial Analysis

Questions? Contact our cannabis specialists at info@houlihancapital.com or 312.450.8600

This content is for informational purposes only and does not constitute investment or legal advice. Always consult qualified professionals regarding cannabis business operations and compliance.